Patents by Inventor Steven Marc Paul

Steven Marc Paul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of antibodies having high affinity for soluble ab to treat conditions and diseases related to ass
    Publication number: 20040241164
    Abstract: The invention provides a method for treating a subject having a condition or disease related to the A&bgr; peptide comprising administering to the subject an antibody that recognizes A&bgr;, wherein the antibody has an affinity for soluble A&bgr; higher than 10−9M.
    Type: Application
    Filed: February 17, 2004
    Publication date: December 2, 2004
    Inventors: Kelly Renee Bales, Steven Marc Paul
  • Methods for increasing levels of acetylcholine
    Patent number: 6395719
    Abstract: The present invention is directed to increasing levels of acetylcholine by the administration of 2-aryl-3-aroylbenzo[b]thiophenes.
    Type: Grant
    Filed: November 14, 2000
    Date of Patent: May 28, 2002
    Assignee: Eli Lilly and Company
    Inventors: Henry Uhlman Bryant, Michele Annette Glinn, Steven Marc Paul, Xin Wu
  • Treatment of central nervous system disorders with selective estrogen receptor modulators
    Publication number: 20020013342
    Abstract: The present invention provides a method of treating depression, mood swings, or Alzheimer's disease in a patient in need of such treatment by administering a selective estrogen receptor modulating compound of the formula 1
    Type: Application
    Filed: May 4, 2000
    Publication date: January 31, 2002
    Inventors: Kelly Renee Bales, Henry Uhlman Bryant, Steven Marc Paul, Mary Patricia Knadler
  • Methods for increasing levels of acetylcholine
    Publication number: 20010041745
    Abstract: The current invention relates to a method for increasing levels of acetylcholine in mammals comprising administering to a mammal in need thereof, an effective amount of a compound of formula I: 1
    Type: Application
    Filed: March 27, 2000
    Publication date: November 15, 2001
    Inventors: Henry Uhlman Bryant, Steven Marc Paul, Xin Wu, Michele Annette Glinn
  • Methods for increasing levels of acetylcholine
    Patent number: 6288108
    Abstract: The current invention relates to a method for increasing levels of acetylcholine comprising administering to a mammal in need thereof, an effective amount of a compound of formula (I), and optionally an AChE inhibitor.
    Type: Grant
    Filed: November 14, 2000
    Date of Patent: September 11, 2001
    Assignee: Eli Lilly and Company
    Inventors: Henry Uhlman Bryant, Michele Annette Glinn, Steven Marc Paul, Xin Wu
  • Treatment of central nervous system disorders with selective estrogen receptor modulators
    Patent number: 6077852
    Abstract: The present invention provides a method of treating depression, mood swings, or Alzheimer's disease in a patient in need of such treatment by administering a selective estrogen receptor modulating compound of the formula ##STR1## in which R.sup.1 and R.sup.2 are independently hydroxy and alkoxy of one to four carbon atoms; and R.sup.3 and R.sup.4 are independently methyl or ethyl, or R.sup.3 and R.sup.4, taken together with the nitrogen atom to which they are attached, form a pyrrolidino, methyl-pyrrolidino, dimethylpyrrolidino, piperidino, morpholino, or hexamethyleneimino ring.
    Type: Grant
    Filed: April 9, 1998
    Date of Patent: June 20, 2000
    Assignee: Eli Lilly and Company
    Inventors: Kelly Renee Bales, Henry Uhlman Bryant, Steven Marc Paul, Mary Patricia Knadler
  • Treatment of attention-deficit/hyperactivity disorder
    Patent number: 5696168
    Abstract: A group of propanamines, norepinephrine uptake inhibitors, are used to treat attention-deficit/hyperactivity disorder.
    Type: Grant
    Filed: July 16, 1996
    Date of Patent: December 9, 1997
    Assignee: Eli Lilly and Company
    Inventors: John Harrison Heiligenstein, Bennett Coleman Laguzza, Steven Marc Paul, Gary Dennis Tollefson